US Stock MarketDetailed Quotes

Entrada Therapeutics (TRDA)

Watchlist
  • 11.430
  • -0.280-2.39%
Close Jan 23 16:00 ET
  • 11.430
  • 0.0000.00%
Post 17:14 ET
436.85MMarket Cap-4.45P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Entrada Therapeutics (TRDA) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-16.68%-28.31M
-174.03%-29.49M
-50.90%-38.51M
-129.73%-41.56M
-687.57%-31.61M
0.92%-24.27M
213.51%39.83M
-112.55%-25.52M
249.07%139.8M
85.30%-4.01M
Net income from continuing operations
-214.52%-44.13M
-178.32%-43.1M
-173.84%-17.35M
1,081.69%65.63M
111.85%1.13M
-139.57%-14.03M
312.25%55.03M
452.05%23.5M
92.93%-6.69M
61.25%-9.54M
Depreciation and amortization
31.27%1.23M
13.63%1.03M
1.28%946K
32.81%3.77M
34.78%992K
12.35%937K
24.66%910K
72.64%934K
49.92%2.84M
39.92%736K
Change In working capital
179.68%10.21M
145.99%8.49M
49.94%-25.85M
-187.19%-118.85M
-1,316.42%-35.92M
79.44%-12.82M
-63.14%-18.47M
-124.95%-51.65M
1,326.85%136.32M
149.39%2.95M
-Change in receivables
-100.32%-16K
-98.76%864K
102.28%1.64M
137.39%2.2M
-26.26%-1.08M
495.86%5.07M
2,635.61%69.84M
-1,037.62%-71.64M
---5.88M
---853K
-Change in prepaid assets
393.32%3.73M
262.95%4.68M
-184.81%-2.27M
-151.46%-4.44M
-123.75%-2.97M
91.39%-1.27M
-143.88%-2.87M
-38.23%2.68M
161.49%8.62M
725.17%12.52M
-Change in payables and accrued expense
555.03%5.67M
414.69%3.19M
-437.44%-7.23M
-113.08%-658K
-90.02%837K
114.60%865K
51.04%-1.01M
-129.00%-1.35M
-28.63%5.03M
3,240.64%8.39M
-Change in other current assets
37.53%3.6M
-39.35%2.78M
7.11%2.74M
2,922.54%12.88M
201.26%3.12M
43.47%2.61M
59.77%4.59M
148.29%2.56M
-87.14%426K
146.70%1.03M
-Change in other current liabilities
25.12%-2.34M
-13.32%-2.25M
-22.91%-2.21M
23.93%-9.02M
-350.54%-2.11M
20.98%-3.13M
70.72%-1.99M
7.79%-1.8M
-59.20%-11.86M
141.76%841K
-Change in other working capital
97.53%-419K
99.12%-770K
-203.46%-18.51M
-185.59%-119.81M
-77.73%-33.72M
55.60%-16.97M
-503.22%-87.02M
-91.54%17.9M
--139.98M
---18.97M
Cash from discontinued investing activities
Operating cash flow
-16.68%-28.31M
-174.03%-29.49M
-50.90%-38.51M
-129.73%-41.56M
-687.57%-31.61M
0.92%-24.27M
213.51%39.83M
-112.55%-25.52M
249.07%139.8M
85.30%-4.01M
Investing cash flow
Cash flow from continuing investing activities
159.22%49.11M
238.61%33.8M
-81.71%4.78M
79.91%-27.8M
180.23%53.37M
-2,119.08%-82.93M
78.47%-24.38M
164.65%26.15M
6.90%-138.4M
1.34%19.04M
Net PPE purchase and sale
126.76%171K
73.71%-275K
-36.52%-1.14M
43.75%-3.16M
34.94%-635K
55.87%-639K
31.27%-1.05M
49.76%-838K
-94.46%-5.61M
-37.85%-976K
Net investment purchase and sale
159.47%48.94M
246.00%34.07M
-78.04%5.93M
81.44%-24.64M
169.74%54M
-3,494.93%-82.29M
79.11%-23.34M
169.59%26.99M
8.91%-132.78M
2.66%20.02M
Cash from discontinued investing activities
Investing cash flow
159.22%49.11M
238.61%33.8M
-81.71%4.78M
79.91%-27.8M
180.23%53.37M
-2,119.08%-82.93M
78.47%-24.38M
164.65%26.15M
6.90%-138.4M
1.34%19.04M
Financing cash flow
Cash flow from continuing financing activities
172.73%8K
-99.67%337K
69.90%350K
389.44%102.96M
103.19%1.4M
-102.99%-11K
22,781.94%101.37M
-98.95%206K
4,291.86%21.04M
92.74%690K
Net common stock issuance
--0
----
----
413.26%99.61M
--0
---392K
--100M
--0
--19.41M
--0
Proceeds from stock option exercised by employees
-97.90%8K
-75.35%337K
69.90%350K
105.89%3.36M
103.19%1.4M
3.53%381K
208.58%1.37M
59.69%206K
240.29%1.63M
92.74%690K
Cash from discontinued financing activities
Financing cash flow
172.73%8K
-99.67%337K
69.90%350K
389.44%102.96M
103.19%1.4M
-102.99%-11K
22,781.94%101.37M
-98.95%206K
4,291.86%21.04M
92.74%690K
Net cash flow
Beginning cash position
-59.60%76.43M
-0.83%71.79M
46.97%105.16M
45.71%71.55M
46.87%82M
126.07%189.2M
-68.74%72.39M
45.71%71.55M
-83.13%49.11M
-2.50%55.83M
Current changes in cash
119.41%20.8M
-96.02%4.65M
-4,101.68%-33.37M
49.74%33.61M
47.34%23.16M
-284.78%-107.2M
178.98%116.82M
-99.54%834K
109.28%22.45M
292.79%15.72M
End cash Position
18.58%97.24M
-59.60%76.43M
-0.83%71.79M
46.97%105.16M
46.97%105.16M
46.87%82M
126.07%189.2M
-68.74%72.39M
45.71%71.55M
45.71%71.55M
Free cash flow
-13.00%-28.14M
-176.74%-29.76M
-50.44%-39.65M
-133.32%-44.72M
-546.22%-32.24M
3.99%-24.91M
205.94%38.79M
-113.07%-26.36M
238.81%134.19M
82.19%-4.99M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -16.68%-28.31M-174.03%-29.49M-50.90%-38.51M-129.73%-41.56M-687.57%-31.61M0.92%-24.27M213.51%39.83M-112.55%-25.52M249.07%139.8M85.30%-4.01M
Net income from continuing operations -214.52%-44.13M-178.32%-43.1M-173.84%-17.35M1,081.69%65.63M111.85%1.13M-139.57%-14.03M312.25%55.03M452.05%23.5M92.93%-6.69M61.25%-9.54M
Depreciation and amortization 31.27%1.23M13.63%1.03M1.28%946K32.81%3.77M34.78%992K12.35%937K24.66%910K72.64%934K49.92%2.84M39.92%736K
Change In working capital 179.68%10.21M145.99%8.49M49.94%-25.85M-187.19%-118.85M-1,316.42%-35.92M79.44%-12.82M-63.14%-18.47M-124.95%-51.65M1,326.85%136.32M149.39%2.95M
-Change in receivables -100.32%-16K-98.76%864K102.28%1.64M137.39%2.2M-26.26%-1.08M495.86%5.07M2,635.61%69.84M-1,037.62%-71.64M---5.88M---853K
-Change in prepaid assets 393.32%3.73M262.95%4.68M-184.81%-2.27M-151.46%-4.44M-123.75%-2.97M91.39%-1.27M-143.88%-2.87M-38.23%2.68M161.49%8.62M725.17%12.52M
-Change in payables and accrued expense 555.03%5.67M414.69%3.19M-437.44%-7.23M-113.08%-658K-90.02%837K114.60%865K51.04%-1.01M-129.00%-1.35M-28.63%5.03M3,240.64%8.39M
-Change in other current assets 37.53%3.6M-39.35%2.78M7.11%2.74M2,922.54%12.88M201.26%3.12M43.47%2.61M59.77%4.59M148.29%2.56M-87.14%426K146.70%1.03M
-Change in other current liabilities 25.12%-2.34M-13.32%-2.25M-22.91%-2.21M23.93%-9.02M-350.54%-2.11M20.98%-3.13M70.72%-1.99M7.79%-1.8M-59.20%-11.86M141.76%841K
-Change in other working capital 97.53%-419K99.12%-770K-203.46%-18.51M-185.59%-119.81M-77.73%-33.72M55.60%-16.97M-503.22%-87.02M-91.54%17.9M--139.98M---18.97M
Cash from discontinued investing activities
Operating cash flow -16.68%-28.31M-174.03%-29.49M-50.90%-38.51M-129.73%-41.56M-687.57%-31.61M0.92%-24.27M213.51%39.83M-112.55%-25.52M249.07%139.8M85.30%-4.01M
Investing cash flow
Cash flow from continuing investing activities 159.22%49.11M238.61%33.8M-81.71%4.78M79.91%-27.8M180.23%53.37M-2,119.08%-82.93M78.47%-24.38M164.65%26.15M6.90%-138.4M1.34%19.04M
Net PPE purchase and sale 126.76%171K73.71%-275K-36.52%-1.14M43.75%-3.16M34.94%-635K55.87%-639K31.27%-1.05M49.76%-838K-94.46%-5.61M-37.85%-976K
Net investment purchase and sale 159.47%48.94M246.00%34.07M-78.04%5.93M81.44%-24.64M169.74%54M-3,494.93%-82.29M79.11%-23.34M169.59%26.99M8.91%-132.78M2.66%20.02M
Cash from discontinued investing activities
Investing cash flow 159.22%49.11M238.61%33.8M-81.71%4.78M79.91%-27.8M180.23%53.37M-2,119.08%-82.93M78.47%-24.38M164.65%26.15M6.90%-138.4M1.34%19.04M
Financing cash flow
Cash flow from continuing financing activities 172.73%8K-99.67%337K69.90%350K389.44%102.96M103.19%1.4M-102.99%-11K22,781.94%101.37M-98.95%206K4,291.86%21.04M92.74%690K
Net common stock issuance --0--------413.26%99.61M--0---392K--100M--0--19.41M--0
Proceeds from stock option exercised by employees -97.90%8K-75.35%337K69.90%350K105.89%3.36M103.19%1.4M3.53%381K208.58%1.37M59.69%206K240.29%1.63M92.74%690K
Cash from discontinued financing activities
Financing cash flow 172.73%8K-99.67%337K69.90%350K389.44%102.96M103.19%1.4M-102.99%-11K22,781.94%101.37M-98.95%206K4,291.86%21.04M92.74%690K
Net cash flow
Beginning cash position -59.60%76.43M-0.83%71.79M46.97%105.16M45.71%71.55M46.87%82M126.07%189.2M-68.74%72.39M45.71%71.55M-83.13%49.11M-2.50%55.83M
Current changes in cash 119.41%20.8M-96.02%4.65M-4,101.68%-33.37M49.74%33.61M47.34%23.16M-284.78%-107.2M178.98%116.82M-99.54%834K109.28%22.45M292.79%15.72M
End cash Position 18.58%97.24M-59.60%76.43M-0.83%71.79M46.97%105.16M46.97%105.16M46.87%82M126.07%189.2M-68.74%72.39M45.71%71.55M45.71%71.55M
Free cash flow -13.00%-28.14M-176.74%-29.76M-50.44%-39.65M-133.32%-44.72M-546.22%-32.24M3.99%-24.91M205.94%38.79M-113.07%-26.36M238.81%134.19M82.19%-4.99M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.28%
Sample Name
Sample Code
 +3.09%
Sample Name
Sample Code
 +2.74%
4
Amazon
AMZN
+2.06%
5
Clean Energy Fuels
CLNE
+1.75%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +20.18%
Sample Name
Sample Code
 +8.06%
Sample Name
Sample Code
 +4.49%
4
KE Holdings
BEKE
+3.82%
5
Pony AI
PONY
+3.59%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -